glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://ignitenutrition.ca/wp-content/uploads/2025/03/GLP-1-inhibitors-Gastroparesis-Main-Image-1024x683.png)
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://i.postimg.cc/mkBjtwK4/glip-1-vs-gip-chart.jpg)
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41366-025-01749-x/MediaObjects/41366_2025_1749_Fig1_HTML.png)
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0168822726002524-gr2.jpg)
![glp 1 agonist delayed gastric emptying Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual volume was higher when GLP-1/GIP agonists were continued vs held for glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/1085799/xml-images/fendo-14-1085799-g001.webp)


.webp)





/assets/images/provider/photos/2775905.jpeg)










